Sensus Healthcare Stock Performance
| SRTS Stock | USD 4.46 0.01 0.22% |
On a scale of 0 to 100, Sensus Healthcare holds a performance score of 9. The entity has a beta of 1.57, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sensus Healthcare will likely underperform. Please check Sensus Healthcare's potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to make a quick decision on whether Sensus Healthcare's existing price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Sensus Healthcare are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Sensus Healthcare unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.22 | Five Day Return 14.36 | Year To Date Return 8.78 | Ten Year Return (23.76) | All Time Return (23.76) |
1 | Thermo Fisher Scientific Beats Q3 Earnings and Revenue Estimates | 10/22/2025 |
2 | CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer | 11/04/2025 |
3 | Insider Trading | 11/10/2025 |
4 | Acquisition by Michael Sardano of 1000 shares of Sensus Healthcare at 4.26 subject to Rule 16b-3 | 11/11/2025 |
5 | Sensus Healthcare appoints Michael Sardano as chief commercial officer SRTS | 11/14/2025 |
6 | Will Sensus Healthcare Inc. stock see insider buying - July 2025 Macro Moves Free Technical Pattern Based Buy Signals - newser.com | 11/17/2025 |
7 | Acquisition by Michael Sardano of 1000 shares of Sensus Healthcare at 3.8 subject to Rule 16b-3 | 11/18/2025 |
8 | Sachetta Eric buys 11k in Sensus Healthcare - Investing.com | 11/20/2025 |
9 | Acquisition by Sachetta Eric of 7000 shares of Sensus Healthcare at 3.93 subject to Rule 16b-3 | 11/21/2025 |
10 | Acquisition by Michael Sardano of 40000 shares of Sensus Healthcare subject to Rule 16b-3 | 12/12/2025 |
11 | Disposition of 35 shares by Javier Rampolla of Sensus Healthcare at 3.03 subject to Rule 16b-3 | 12/17/2025 |
12 | Disposition of 13253 shares by Cohen Stephen Brad of Sensus Healthcare at 6.99 subject to Rule 16b-3 | 01/02/2026 |
| Begin Period Cash Flow | 23.1 M | |
| Total Cashflows From Investing Activities | -276 K |
Sensus Healthcare Relative Risk vs. Return Landscape
If you would invest 340.00 in Sensus Healthcare on October 9, 2025 and sell it today you would earn a total of 106.00 from holding Sensus Healthcare or generate 31.18% return on investment over 90 days. Sensus Healthcare is currently generating 0.538% in daily expected returns and assumes 4.4396% risk (volatility on return distribution) over the 90 days horizon. In different words, 39% of stocks are less volatile than Sensus, and 90% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Sensus Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sensus Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sensus Healthcare, and traders can use it to determine the average amount a Sensus Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1212
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SRTS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Sensus Healthcare is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sensus Healthcare by adding it to a well-diversified portfolio.
Sensus Healthcare Fundamentals Growth
Sensus Stock prices reflect investors' perceptions of the future prospects and financial health of Sensus Healthcare, and Sensus Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sensus Stock performance.
| Return On Equity | -0.0571 | ||||
| Return On Asset | -0.0575 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | 0.41 % | ||||
| Current Valuation | 49.17 M | ||||
| Shares Outstanding | 16.43 M | ||||
| Price To Earning | 4.30 X | ||||
| Price To Book | 1.43 X | ||||
| Price To Sales | 2.06 X | ||||
| Revenue | 41.81 M | ||||
| Gross Profit | 17.08 M | ||||
| EBITDA | 8.52 M | ||||
| Net Income | 6.65 M | ||||
| Cash And Equivalents | 33.7 M | ||||
| Cash Per Share | 2.04 X | ||||
| Total Debt | 602 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 5.01 X | ||||
| Book Value Per Share | 1.57 X | ||||
| Cash Flow From Operations | (831 K) | ||||
| Earnings Per Share | (0.18) X | ||||
| Market Capitalization | 73.32 M | ||||
| Total Asset | 62.16 M | ||||
| Retained Earnings | 13.43 M | ||||
| Working Capital | 50.85 M | ||||
About Sensus Healthcare Performance
Assessing Sensus Healthcare's fundamental ratios provides investors with valuable insights into Sensus Healthcare's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Sensus Healthcare is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 190.89 | 126.00 | |
| Return On Tangible Assets | 0.10 | 0.10 | |
| Return On Capital Employed | 0.13 | 0.14 | |
| Return On Assets | 0.10 | 0.10 | |
| Return On Equity | 0.12 | 0.11 |
Things to note about Sensus Healthcare performance evaluation
Checking the ongoing alerts about Sensus Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sensus Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sensus Healthcare appears to be risky and price may revert if volatility continues | |
| Sensus Healthcare currently holds about 33.7 M in cash with (831 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04. | |
| Roughly 18.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from prnewswire.com: IceCure Expected to Report Record Fourth Quarter Sales in North America Driven by Recent FDA Clearance of ProSense Cryoablation for Low-Risk Breast Cancer |
- Analyzing Sensus Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sensus Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Sensus Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sensus Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sensus Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sensus Healthcare's stock. These opinions can provide insight into Sensus Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Sensus Stock Analysis
When running Sensus Healthcare's price analysis, check to measure Sensus Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensus Healthcare is operating at the current time. Most of Sensus Healthcare's value examination focuses on studying past and present price action to predict the probability of Sensus Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensus Healthcare's price. Additionally, you may evaluate how the addition of Sensus Healthcare to your portfolios can decrease your overall portfolio volatility.